SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Smulders Y. M.)
 

Search: WFRF:(Smulders Y. M.) > EULAR recommendatio...

  • Agca, R.Amsterdam UMC - Vrije Universiteit Amsterdam (author)

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2016-10-03
  • BMJ,2017

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/260468
  • https://gup.ub.gu.se/publication/260468URI
  • https://doi.org/10.1136/annrheumdis-2016-209775DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-131644URI
  • https://lup.lub.lu.se/record/58c284e2-143e-4ee8-87fe-3484a06f96acURI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommended screening, identification of CVD risk factors and CVD risk management largely based on expert opinion. In view of substantial new evidence, an update was conducted with the aim of producing CVD risk management recommendations for patients with IJD that now incorporates an increasing evidence base. A multidisciplinary steering committee (representing 13 European countries) comprised 26 members including patient representatives, rheumatologists, cardiologists, internists, epidemiologists, a health professional and fellows. Systematic literature searches were performed and evidence was categorised according to standard guidelines. The evidence was discussed and summarised by the experts in the course of a consensus finding and voting process. Three overarching principles were defined. First, there is a higher risk for CVD in patients with RA, and this may also apply to ankylosing spondylitis and psoriatic arthritis. Second, the rheumatologist is responsible for CVD risk management in patients with IJD. Third, the use of non-steroidal anti-inflammatory drugs and corticosteroids should be in accordance with treatment-specific recommendations from EULAR and Assessment of Spondyloarthritis International Society. Ten recommendations were defined, of which one is new and six were changed compared with the 2009 recommendations. Each designated an appropriate evidence support level. The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased. This underscores the need for CVD risk management in these patients. These recommendations are defined to provide assistance in CVD risk management in IJD, based on expert opinion and scientific evidence.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Heslinga, S. C.Amsterdam UMC - Vrije Universiteit Amsterdam (author)
  • Rollefstad, S.Diakonhjemmet Hospital (author)
  • Heslinga, M.Amsterdam UMC - Vrije Universiteit Amsterdam (author)
  • McInnes, I. B.University of Glasgow (author)
  • Peters, M. J.Amsterdam UMC - Vrije Universiteit Amsterdam (author)
  • Kvien, T. K.Diakonhjemmet Hospital (author)
  • Dougados, M.Paris Descartes University,University of Manchester (author)
  • Radner, H.Medical University of Vienna (author)
  • Atzeni, F.Istituto Ortopedico Galeazzi (author)
  • Primdahl, J.University of Southern Denmark,Hospital of Southern Jutland (author)
  • Södergren, AnnaUmeå University,Umeå universitet,Reumatologi(Swepub:umu)anayxt97 (author)
  • Wållberg Jonsson, SolveigUmeå University,Umeå universitet,Reumatologi(Swepub:umu)sowa0001 (author)
  • van Rompay, J.PARE (patient research partners) (author)
  • Zabalan, C. (author)
  • Pedersen, T. R.University of Oslo (author)
  • Jacobsson, Lennart T. H.,1954University of Gothenburg,Lund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups(Swepub:lu)orto-lja (author)
  • de Vlam, K.University Hospitals Leuven (author)
  • Gonzalez-Gay, M. A.University of Cantabria (author)
  • Semb, A. G.Diakonhjemmet Hospital (author)
  • Kitas, G. D.University of Manchester (author)
  • Smulders, Y. M.Amsterdam UMC - Vrije Universiteit Amsterdam (author)
  • Szekanecz, Z.University of Debrecen (author)
  • Sattar, N.University of Glasgow (author)
  • Symmons, D. P. (author)
  • Nurmohamed, M. T.Amsterdam UMC - Vrije Universiteit Amsterdam (author)
  • Amsterdam UMC - Vrije Universiteit AmsterdamDiakonhjemmet Hospital (creator_code:org_t)

Related titles

  • In:Ann Rheum Dis: BMJ76:1, s. 17-280003-49671468-2060
  • In:Annals of the Rheumatic Diseases: BMJ76:1, s. 17-281468-2060

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view